Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

STAVUDINE

STAVUDINE

Standard Dose
1MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview STAVUDINE is listed in Drugs@FDA under application 078030 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient STAVUDINE Form and strength FOR SOLUTION;ORAL - 1MG/ML Sponsor CIPLA LTD Submission history Latest submission status date: 2020-02-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview STAVUDINE is listed in Drugs@FDA under application 078030 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient STAVUDINE Form and strength FOR SOLUTION;ORAL - 1MG/ML Sponsor CIPLA LTD Submission history Latest submission status date: 2020-02-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.